apollo
logo
0Login
Introducing Our Latest Arrival!
Buprigesic 20mcg/hr Transdermal Patch 1's

Buprigesic 20mcg/hr Transdermal Patch 1's

Consult Doctor
Not for online sale
Prescription drug
 Trailing icon

Consume Type

TOPICAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

About Buprigesic 20mcg/hr Transdermal Patch 1's

Buprigesic 20mcg/hr Transdermal Patch 1's belongs to a class of drugs called 'opioid analgesics' primarily used to treat, prevent and treat severe pain. Pain can be temporary (acute) or long-lasting (chronic) in nature. Acute pain is caused by damage to the tissues of the muscle, bone, or other organs for a short time. Chronic pain lasts for a long duration and is caused due to pathologies like nerve damage and osteoarthritis.

Buprigesic 20mcg/hr Transdermal Patch 1's contains 'Buprenorphine', an opioid partial agonist-antagonists. It works by blocking a chemical messenger in the brain responsible for causing pain. This provides pain relief by acting on specific receptors in the brain and helps in relieving pain.

Use Buprigesic 20mcg/hr Transdermal Patch 1's as advised by your doctor. You may experience certain side effects in some cases, including drowsiness, dry mouth, vomiting, blurred vision, constipation, application site reactions, dizziness or tiredness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Buprigesic 20mcg/hr Transdermal Patch 1's should be avoided if you are allergic to it or any ingredients of it or opioids. Do not use Buprigesic 20mcg/hr Transdermal Patch 1's if you are pregnant or breastfeeding. Buprigesic 20mcg/hr Transdermal Patch 1's is not recommended for children below 18 years of age. Buprigesic 20mcg/hr Transdermal Patch 1's is a habit-forming drug; hence there is a risk of dependence. Do not stop using this medicine without consulting your doctor, as it may cause withdrawal symptoms like anxiety, increased heart rate, tremors or general unwell feelings. Buprigesic 20mcg/hr Transdermal Patch 1's may decrease fertility in men and women. Do not consume alcohol while using Buprigesic 20mcg/hr Transdermal Patch 1's as it may increase the risk of side effects.

Uses of Buprigesic 20mcg/hr Transdermal Patch 1's

Pain

Medicinal Benefits

The Buprigesic 20mcg/hr Transdermal Patch 1's contains Buprenorphine. It provides pain relief by acting on specific receptors in the brain and helps in relieving pain. Compared to other opioid analgesics like methadone, Buprigesic 20mcg/hr Transdermal Patch 1's has the advantage of having less sedation (sleepiness), decreased respiratory depression, decreased risk of diversion, fewer withdrawal symptoms and lower risk of toxicity at higher doses. 

Directions for Use

Transdermal Patch: Use Buprigesic 20mcg/hr Transdermal Patch 1's only as prescribed by a doctor. Do not use this medicine for a prolonged period.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Buprigesic 20mcg/hr Transdermal Patch 1's

  • Weakness
  • Anxiety
  • Nervousness
  • Dizziness
  • Headache
  • Constipation
  • Diarrhea
  • Nausea
  • Vomiting
  • Sweating
  • Application site reactions

Drug Warnings

Please do not stop using Buprigesic 20mcg/hr Transdermal Patch 1's suddenly, as it may cause withdrawal symptoms. Avoid frequent or high doses as it may lead to addiction. If you are known to be allergic to Buprigesic 20mcg/hr Transdermal Patch 1's or any other medicines, please tell your doctor. Do not use Buprigesic 20mcg/hr Transdermal Patch 1's if you are pregnant or breastfeeding, as it may cause adverse effects on the baby. Buprigesic 20mcg/hr Transdermal Patch 1's is not recommended for children below 18 years of age. Avoid consuming alcohol with Buprigesic 20mcg/hr Transdermal Patch 1's as it may increase the risk of side effects. Do not use this medicine if you have used an MAO inhibitor (antidepressants) in the past 14 days, as a dangerous drug interaction could occur. Buprigesic 20mcg/hr Transdermal Patch 1's should be taken with extreme caution in patients who have a history of alcoholism or drug abuse. Inform your doctor if you have severe breathing problems, asthma, delirium tremens (confusion and shaking after stopping drinking alcohol), hallucinations (seeing and hearing things that are not there), kidney or liver problems, head injury or brain disease, low blood pressure, urinary disorders (especially linked to enlarged prostate), thyroid problems, adrenocortical disorder (Addison’s disease), depression or other conditions that are treated with antidepressants. 

Drug Interactions

Drug-Drug Interactions: Buprigesic 20mcg/hr Transdermal Patch 1's may have interaction with benzodiazepines (diazepam, temazepam ), pain killers (pentazocine, nalbuphine, codeine, dihydrocodeine, methadone, morphine), anti-depressants (moclobemide, tranylcypromine, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, doxepin, trimipramine), antihistamine (promethazine, chlorphenamine), blood thinners (warfarin), anti-anxiety drugs (alprazolam), fits related medicines (carbamazepine), medicines used to prevent nausea (ondansetron), antifungal drugs (ketoconazole), antibiotic (ciprofloxacin, erythromycin), anticancer drugs (ceritinib, lapatinib), immunosuppressants (fingolimod), antipsychotics (droperidol), and HIV/AIDS drugs (saquinavir).

Drug-Food Interactions: Buprigesic 20mcg/hr Transdermal Patch 1's may interact with grapefruit juice. Therefore, avoid grapefruit juice intake with Buprigesic 20mcg/hr Transdermal Patch 1's as it may increase Buprigesic 20mcg/hr Transdermal Patch 1's levels in the body. Also, avoid St. John's wort (antidepressants plant) and alcohol consumption while using Buprigesic 20mcg/hr Transdermal Patch 1's as it may increase the risk of adverse effects such as drowsiness, dizziness and difficulty concentrating.

Drug-Disease Interactions: People with asthma or any other breathing problems, kidney problems, liver problems, head injury or brain disease, low blood pressure, urinary disorders (especially linked to enlarged prostate), thyroid problems, adrenocortical disorder (Addison’s disease), depression should consult a doctor before using Buprigesic 20mcg/hr Transdermal Patch 1's.

Drug-Drug Interactions Checker List

  • ESCITALOPRAM
  • CITALOPRAM
  • METHADONE
  • FLUOXETINE
  • DIAZEPAM
  • CODEINE
  • MORPHINE
  • AMITRIPTYLINE
  • PROMETHAZINE
  • VENLAFAXINE

Habit Forming

Yes

Diet & Lifestyle Advise

  • Do not go for heavy exercise as it may increase your joint pain in arthritis. Instead, you can do stretching and low-impact aerobic exercises like walking on a treadmill, bike riding, and swimming. You can also strengthen your muscles by lifting light weights.
  • Drink plenty of water during treatment with Buprigesic 20mcg/hr Transdermal Patch 1's to avoid dry mouth.
  • Maintain a fibre-rich diet and eat plenty of fresh fruits and vegetables to avoid constipation while using Buprigesic 20mcg/hr Transdermal Patch 1's.
  • Avoid consumption of alcohol and quit smoking.

Special Advise

  • Do not use Buprigesic 20mcg/hr Transdermal Patch 1's for a prolonged time, as it may lead to mental or physical dependence on Buprigesic 20mcg/hr Transdermal Patch 1's.
  • To avoid getting addicted to this drug, take it in prescribed quantities and as directed by your doctor. Do not self-medicate.
  • Buprigesic 20mcg/hr Transdermal Patch 1's causes drowsiness. Avoid doing activities that require your complete focus and attention, like driving when on this drug.
  • An abrupt stoppage of Buprigesic 20mcg/hr Transdermal Patch 1's can lead to significant withdrawal symptoms. Always discuss with your doctor about decreasing the dosage before completely stopping its usage.
  • Avoid consuming alcohol while on this medication, as it can lead to dangerous side effects.

Disease/Condition Glossary

Pain: It can be short-term (acute) or long-term (chronic) in nature. Acute pain is, for a short time, caused by damage to the tissues of the muscle, bone, or organs. Chronic pain lasts for a longer duration and is caused due to pathologies like nerve damage, osteoarthritis, and dental pain due to damage to the tooth nerve, infection, decay, extraction, or injury. Many women have painful periods known as dysmenorrhea, most often menstrual cramps. On the other hand, Osteoarthritis is a degenerative disease that results in chronic pain in joints (especially knee) and stiffness, making daily tasks difficult.

Country of origin

INDIA
Other Info - BUP0043

FAQs

Buprigesic 20mcg/hr Transdermal Patch 1's consists of Buprenorphine is an opioid partial agonist. It provides pain relief by acting on specific receptors in the brain that change how your body feels and responds to pain.
No, you are not recommended to take Buprigesic 20mcg/hr Transdermal Patch 1's with antidepressants (medicines used to treat depression), and antipsychotics (medicines used to treat bipolar disorder and psychosis) as co-administration of these medicines with Buprigesic 20mcg/hr Transdermal Patch 1's may cause life-threatening respiratory depression and death have occurred. However, please consult a doctor before taking Buprigesic 20mcg/hr Transdermal Patch 1's with other medicines.
Yes, Buprigesic 20mcg/hr Transdermal Patch 1's may cause withdrawal symptoms such as sweating, feeling hot and cold, runny eyes and nose, feeling or being sick, diarrhoea, stomach cramps, poor sleep, and just feeling awful. Therefore, if you experience any difficulty while using Buprigesic 20mcg/hr Transdermal Patch 1's, do not stop using it suddenly and consult your doctor so that the dose may be reduced gradually to avoid withdrawal symptoms.
Yes, Buprigesic 20mcg/hr Transdermal Patch 1's may cause addiction, especially if taken for a prolonged time. Therefore, Buprigesic 20mcg/hr Transdermal Patch 1's should be given only for a short duration under strict medical supervision, particularly to patients susceptible to drug abuse. Take Buprigesic 20mcg/hr Transdermal Patch 1's only as advised by a doctor, as overuse or misuse of Buprigesic 20mcg/hr Transdermal Patch 1's can lead to overdose or death.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Unsafe

Consuming alcohol or other illicit drugs during treatment with Buprigesic 20mcg/hr Transdermal Patch 1's increases your chances of experiencing these significant, life-threatening adverse effects. Throughout your therapy, do not consume alcohol, use alcohol-containing prescription or nonprescription medicines, or use street drugs.

bannner image

Pregnancy

Unsafe

If you are pregnant or planning pregnancy, inform your doctor. If you use Buprigesic 20mcg/hr Transdermal Patch 1's often throughout your pregnancy, your baby may suffer from potentially fatal withdrawal symptoms after birth. If your infant exhibits any of the following symptoms, contact your doctor straight away: irritability, hyperactivity, disturbed sleep, high-pitched scream, excessive shaking of a portion of the body, vomiting, diarrhoea, or failure to gain weight.

bannner image

Breast Feeding

Unsafe

If you are nursing, you should avoid using Buprigesic 20mcg/hr Transdermal Patch 1's. Buprenorphine passes into breast milk in small amounts and might cause respiratory issues in your infant. Talk with your doctor; they may prescribe a different pain reliever.

bannner image

Driving

Unsafe

Buprigesic 20mcg/hr Transdermal Patch 1's may cause dizziness, blurred vision or drowsiness in some people. Therefore, avoid driving if you feel drowsy, dizzy or experience any vision problems after using Buprigesic 20mcg/hr Transdermal Patch 1's.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver disease, inform your doctor before using Buprigesic 20mcg/hr Transdermal Patch 1's.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor before using Buprigesic 20mcg/hr Transdermal Patch 1's.

bannner image

Children

Unsafe

Buprigesic 20mcg/hr Transdermal Patch 1's is not recommended for children below 18 years of age as safety and effectiveness have not been established.

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information